Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Neurion Pharmaceuticals
Profile last edited on: 12/19/14      CAGE: 474Y6      UEI:

Business Identifier: Drug discovery
Year Founded
2002
First Award
2004
Latest Award
2007
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

180 North Vinedo Avenue
Pasadena, CA 91107
   (626) 583-5020
   N/A
   www.neurionpharma.com
Location: Single
Congr. District: 27
County: Los Angeles

Public Profile

Neurion Pharmaceuticals, Inc., an ion channel drug discovery company, focuses on the discovery of small molecule drug therapies for diseases and disorders of the central nervous system.

Extent of SBIR involvement

User Avatar
Phase I Awards
6
Phase II Awards
2
Conversion Rate
33.33%
Phase I Dollars
$1,159,844
Phase II Dollars
$534,523
Total Awarded
$1,694,367

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2007 1 NIH $201,331
Project Title: Novel assay to identify non-ATP competitive protein kinase inhibitors
2006 1 NIH $249,170
Project Title: hERG MAP-A rational approach to eliminate ion channel related cardiotoxicity
2006 1 NIH $134,820
Project Title: Cell-Based Technology for Detection & Measurement of Protein-Protein Interactions
2006 2 NIH $560,000
Project Title: Compounds Targeting the Alpha-2 Gaba-A Receptor Subtype
2005 2 NIH $449,046
Project Title: Novel Methods for Functional Brain Imaging

Key People / Management

  William L Robbins -- Chairman, President and CEO

  Kate Hawkes -- Assistant Manager, Business Administration

Company News

There are no news available.